Cargando…
Astrocytic ceramide as possible indicator of neuroinflammation
BACKGROUND: Neurodegenerative diseases such as Alzheimer’s disease (AD), Parkinson’s disease dementia (PDD), and frontotemporal lobar dementia (FTLD) are characterized by progressive neuronal loss but differ in their underlying pathological mechanisms. However, neuroinflammation is commonly observed...
Autores principales: | de Wit, Nienke M., den Hoedt, Sandra, Martinez-Martinez, Pilar, Rozemuller, Annemieke J., Mulder, Monique T., de Vries, Helga E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6388480/ https://www.ncbi.nlm.nih.gov/pubmed/30803453 http://dx.doi.org/10.1186/s12974-019-1436-1 |
Ejemplares similares
-
Sphingolipids in Cerebrospinal Fluid and Plasma Lipoproteins of APOE4 Homozygotes and Non-APOE4 Carriers with Mild Cognitive Impairment versus Subjective Cognitive Decline
por: den Hoedt, Sandra, et al.
Publicado: (2023) -
Effects of Sex, Age, and Apolipoprotein E Genotype on Brain Ceramides and Sphingosine-1-Phosphate in Alzheimer’s Disease and Control Mice
por: den Hoedt, Sandra, et al.
Publicado: (2021) -
CERT(L) reduces C16 ceramide, amyloid-β levels, and inflammation in a model of Alzheimer’s disease
por: Crivelli, Simone M., et al.
Publicado: (2021) -
Neuroinflammation in Alzheimer's disease wanes with age
por: Hoozemans, Jeroen JM, et al.
Publicado: (2011) -
Ceramide analog [(18)F]F-HPA-12 detects sphingolipid disbalance in the brain of Alzheimer’s disease transgenic mice by functioning as a metabolic probe
por: Crivelli, Simone M., et al.
Publicado: (2020)